Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Fortes, Filomeno ^a,b   Dimbu, Rafael ^a,b   Figueiredo, Paula ^b   Neto, Zoraima ^b   Do Rosário, Virgílio E ^b   Lopes, Dinora ^b  

^a Programa Nacional de Controle da Malária   (Angola)

^b INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

INSECT PROTEIN; PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE; PLASMODIUM FALCIPARUM DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE PLUS SULFADOXINE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CASE REPORT; CHILD; CODON; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTOZOAL GENETICS; ANGOLA; CHEMOPROPHYLAXIS; DRUG COMBINATION; DRUG EFFECT; GENE; GENETICS; MULTIDRUG RESISTANCE; MUTATION; PARASITOLOGY; PREGNANCY; PRESCHOOL CHILD;

ANGOLA; ANTIMALARIALS; CHEMOPREVENTION; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; FEMALE; GENES, PROTOZOAN; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; PREGNANCY; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 79251622010     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-22     Document Type: Article

References (49)

1. World Health Organization/UNICEF: World Malaria Report 2005. 2005 [http://whqlibdoc.who.int/publications/2005/9241593199-eng.pdf].
2. Brabin BJ: An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983, 61:1005-1016.
3. Nosten F, ter Kuile F, Maelankirri L, Decludt B, White NJ: Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg 1991, 85:424-429.
4. World Health Organization: Communicable Disease Toolkit for Angola. 2005 [http://whqlibdoc.who.int/hq/2005/WHO-CDS-NTD-DCE-2005a-profile.pdf].
5. Kyronseppa H, Lumio J, Ukkonen R, Pettersson T: Chloroquine-resistant malaria from Angola. Lancet 1984, 1:1244. (Pubitemid 14105877)
6. Olsen VV, Jensen T, Jorgensen M: Chloroquine-resistant Plasmodium falciparum malaria from Angola. Lancet 1984, 1:1462-463.
7. Lindberg J, Sandberg T, Bjorkholm B, Bjorkman A: Chloroquine and Fansidar resistant malaria acquired in Angola. Lancet 1985, 1:765. (Pubitemid 15104993)
8. Guthmann JP, Ampuero J, Fortes F, van Overmeir C, Gaboulaud V, Tobback S, Dunand J, Saraiva N, Gillet P, Franco J, Denoncin A, van Herp M, Balkan S, Dujardin JC, D'Alessandro U, Legros D: Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxinepyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans R Soc Trop Med Hyg 2005, 99:485-492. (Pubitemid 40692060)
9. World Health Organization: Global AMD database. AFRO 2005 [http://www.who.int/countries/en/].
10. Nahlen BL: Rolling back malaria in pregnancy. N Engl J Med 2000, 343:651-652.
11. WHO: A strategic Framework for Malaria Prevention and Control during Pregnancy in the Africa Region. 2004 [http://whqlibdoc.who.int/afro/2004/AFR- MAL-04.01.pdf].
12. Schellenberg DM, Aponte JJ, Kahigwa EA, Mshinda H, Tanner M, Menendez C, Alonso PL: The incidence of clinical malaria detected by active case detection in children in Ifakara, southern Tanzania. Trans R Soc Trop Med Hyg 2003, 97:647-54. (Pubitemid 41051071)
13. Massaga JJ, Kitua AY, Lemnge MM, Akida JA, Malle LN, Rønn AM, Theander TG, Bygbjerg IC: Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet 2003, 361:1853-1860. (Pubitemid 36645180)
14. Chandramohan D, Owusu-Agyei S, Carneiro I, Awine T, Amponsa-Achiano K, Mensah N, Jaffar S, Baiden R, Hodgson A, Binka F, Greenwood B: Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ 2005, 331:727-33. (Pubitemid 41414939)
15. White NJ: Antimalarial drug resistance. J Clin Invest 2004, 113:1084-92.
16. Macete E, Aide P, Aponte JJ, Sanz S, Mandomando I, Espasa M, Sigauque B, Dobaño C, Mabunda S, DgeDge M, Alonso P, Menendez C: Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. J Infect Dis 2006, 194:276-285. (Pubitemid 44116968)
17. Kobbe R, Adjei S, Kreuzberg C, Kreuels B, Thompson B, Thompson PA, Marks F, Busch W, Tosun M, Schreiber N, Opoku E, Adjei O, Meyer CG, May J: Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi). Malar J 2007, 6:163.
18. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR: Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002, 2:209-218. (Pubitemid 34464751)
19. Le Bras J, Durand R: The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam Clin Pharmacol 2003, 17:147-153. (Pubitemid 36513205)
20. Jelinek T, Rønn AM, Lemnge MM, Curtis J, Mhina J, Duraisingh MT, Bygbjerg IC, Warhurst DC: Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania. Trop Med Int Health 1998, 3:605-609. (Pubitemid 28394589)
21. Ngo T, Duraisingh M, Reed M, Hipgrave D, Biggs B, Cowman AF: Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. Am J Trop Med Hyg 2003, 68:350-356. (Pubitemid 38240527)
22. Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ: Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductasethymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 1988, 85:9109-9113. (Pubitemid 19001849)
23. Peterson DS, Walliker D, Wellems TE: Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 1988, 85:9114-9118. (Pubitemid 19001850)
24. Appawu M, Owusu-Agyei S, Dadzie S, Asoala V, Anto F, Koram K, Rogers W, Nkrumah F, Hoffman SL, Fryauff DJ: Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health 2004, 9:164-170. (Pubitemid 38178026)
25. Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergquist Y, Björkman A, Kobayakawa T: High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop 2003, 85:363-373. (Pubitemid 36355874)
26. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV: Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil- dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 2002, 185:380-388. (Pubitemid 34107252)
27. Nzila AM, Mberu EK, Sulo J, Dayo H, Winstanley PA, Sibley CH, Watkins WM: Towards an understanding of the mechanism of pyrimethaminesulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother 2000, 44:991-996. (Pubitemid 30165281)
28. Nsimba B, Jafari-Guemouri S, Malonga DA, Mouata AM, Kiori J, Louya F, Yocka D, Malanda M, Durand R, Le Brás J: Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use. Trop Med Int Health 2005, 10:1030-1037. (Pubitemid 41445068)
29. Aubouy A, Jafari S, Huart V, Migot-Nabias F, Mayombo J, Durand R, Bakary M, Le Bras J, Deloron P: DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy. J Antimicrob Chemother 2003, 52:43-49. (Pubitemid 36850083)
30. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithongs S, Brown KN: High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 1993, 61:315-320.
31. Figueiredo P, Benchimol C, Lopes D, Bernardino L, do Rosário VE, Varandas L, Nogueira F: Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola. Malar J 2008, 7:236.
32. Cravo P, Figueiredo S, Nogueira F, Lopes D, Ferreira ID, Ferreira C, do Rosario VE: High frequency of the genetic polymorphisms associated with sulfadoxine-pyrimethamine resistance, among Plasmodium falciparum isolates from Sao Tome and Principe, West Africa. Ann Trop Med Parasitol 2004, 98:293-296. (Pubitemid 38594738)
33. Mockenhaupt FP, Eggelte TA, Till H, Bienzle U: Plasmodium falciparum pfcrt and pfmdr1 polymorphisms are associated with the pfdhfr N108 pyrimethamine-resistance mutation in isolates from Ghana. Trop Med Int Health 2001, 6:749-755. (Pubitemid 32989626)
34. Durand R, Jafari S, Bouchaud O, Ralaimazava P, Keundjian A, Le Bras J: Plasmodium falciparum: pfcrt and DHFR mutations are associated with failure of chloroquine plus proguanil prophylaxis in travelers. J Infect Dis 2001, 184:1633-1634. (Pubitemid 33139756)
35. Tarnchompoo B, Sirichaiwat C, Phupong W, Intaraudom C, Sirawaraporn W, Kamchonwongpaisan S, Vanichtanankul J, Thebtaranonth Y, Yuthavong Y: Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine resistant Plasmodium falciparum. J Med Chem 2002, 45:1244-1252. (Pubitemid 34263561)
36. Mourier T, Pain A, Barrell B, Griffiths-Jones S: A selenocysteine tRNA and SECIS element in Plasmodium falciparum. RNA 2005, 11:119-122. (Pubitemid 40165626)
37. Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV: Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA 1997, 94:1124-1129. (Pubitemid 27087815)
38. Menegon M, Pearce RJ, Inojosa WO, Pisani V, Abel PM, Matondo A, Bisoffi Z, Majori G, Ord R, Warhurst DC, Roper C, Severini C: Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uíge province, Angola. Trop Med Int Health 2009, 14:1251-1257.
39. Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, Puyol L, Berzosa P, Dobaño C, Aide P, Sacarlal J, Benito A, Alonso P, Menéndez C: Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants. J Infect Dis 2008, 197:1737-1742. (Pubitemid 351919639)
40. Mbugi EV, Mutayoba BM, Malisa AL, Balthazary ST, Nyambo TB, Mshinda H: Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania. Malar J 2006, 5:94.
41. Gama BE, de Oliveira NK, Zalis MG, de Souza JM, Santos F, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F: Chloroquine and sulphadoxinepyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area. Malar J 2009, 8:156.
42. Hapuarachchi HC, Dayanath MY, Bandara KB, Abeysundara S, Abeyewickreme W, de Silva NR, Hunt SY, Siblev CH: Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka. Am J Trop Med Hyg 2006, 74:198-204. (Pubitemid 46774327)
43. Mita T, Kaneko A, Hwaihwanje I, Tsukahara T, Takahashi N, Osawa H, Tanabe K, Kobayakawa T, Björkman A: A rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/ pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea. Infect Genet Evol 2006, 6:447-452. (Pubitemid 44542624)
44. Cox-Singh J, Zakaria R, Abdullah MS, Rahman HA, Nagappan S, Singh B: Differences in dihydrofolate reductase but not dihydropteroate synthase alleles in Plasmodium falciparum isolates from geographically distinct areas in Malaysia. Am J Trop Med Hyg 2001, 64:28-31. (Pubitemid 32550094)
45. Vasconcelos KF, Plowe CV, Fontes CJ, Kyle D, Wirth DF, Pereira da Silva LH, Zalis MG: Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. Mem Inst Oswaldo Cruz 2000, 95:721-728.
46. Das MK, Lumb V, Mittra P, Singh SS, Dash AP, Sharma YD: High chloroquine treatment failure rates and predominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India. J Antimicrob Chemother 2010, 65:1258-1261.
47. Zakeri S, Gil JP, Bereckzy S, Djadid ND, Bjorkman A: High prevalence of double Plasmodium falciparum dhfr mutations at codons 108 and 59 in the Sistan- Baluchistan Province. Iran J Infect Dis 2003, 187:1828-1829. (Pubitemid 36667897)
48. Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Byqbierq IC, Rønn AM: Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity. Am J Trop Med Hyg 2003, 69:601-606. (Pubitemid 38248230)
49. Dokomajilar C, Lankoande ZM, Dorsey G, Zongo I, Ouedraogo JB, Rosenthal PJ: Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso. Am J Trop Med Hyg 2006, 75:162-165. (Pubitemid 351627587)